CA3034235A1 - Systemes et procedes pour determiner et fournir un affichage d'une pluralite de scores de bien-etre - Google Patents
Systemes et procedes pour determiner et fournir un affichage d'une pluralite de scores de bien-etre Download PDFInfo
- Publication number
- CA3034235A1 CA3034235A1 CA3034235A CA3034235A CA3034235A1 CA 3034235 A1 CA3034235 A1 CA 3034235A1 CA 3034235 A CA3034235 A CA 3034235A CA 3034235 A CA3034235 A CA 3034235A CA 3034235 A1 CA3034235 A1 CA 3034235A1
- Authority
- CA
- Canada
- Prior art keywords
- treatment
- patient
- wellness
- score
- omd
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 424
- 238000011282 treatment Methods 0.000 claims abstract description 2103
- 238000003745 diagnosis Methods 0.000 claims abstract description 177
- 230000000694 effects Effects 0.000 claims description 83
- 230000006872 improvement Effects 0.000 description 287
- 230000004044 response Effects 0.000 description 230
- 230000008569 process Effects 0.000 description 208
- 238000011084 recovery Methods 0.000 description 157
- 238000002203 pretreatment Methods 0.000 description 106
- 208000002193 Pain Diseases 0.000 description 92
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 87
- 201000010099 disease Diseases 0.000 description 86
- 230000036407 pain Effects 0.000 description 85
- 238000001356 surgical procedure Methods 0.000 description 69
- 230000036541 health Effects 0.000 description 60
- 238000012360 testing method Methods 0.000 description 53
- 239000003814 drug Substances 0.000 description 44
- 239000013598 vector Substances 0.000 description 41
- 208000024891 symptom Diseases 0.000 description 40
- 229940079593 drug Drugs 0.000 description 39
- 230000008859 change Effects 0.000 description 38
- 238000004891 communication Methods 0.000 description 32
- 238000004458 analytical method Methods 0.000 description 29
- 230000006870 function Effects 0.000 description 29
- 238000003860 storage Methods 0.000 description 28
- 206010003658 Atrial Fibrillation Diseases 0.000 description 23
- 230000006399 behavior Effects 0.000 description 23
- 230000005182 global health Effects 0.000 description 23
- 230000004382 visual function Effects 0.000 description 22
- 239000007943 implant Substances 0.000 description 20
- 238000013150 knee replacement Methods 0.000 description 20
- 238000007726 management method Methods 0.000 description 20
- 208000019901 Anxiety disease Diseases 0.000 description 18
- 230000036506 anxiety Effects 0.000 description 17
- 210000003127 knee Anatomy 0.000 description 17
- 206010028980 Neoplasm Diseases 0.000 description 16
- 201000011510 cancer Diseases 0.000 description 16
- 230000003993 interaction Effects 0.000 description 16
- 208000010668 atopic eczema Diseases 0.000 description 15
- 201000004624 Dermatitis Diseases 0.000 description 14
- 208000019695 Migraine disease Diseases 0.000 description 14
- 230000007423 decrease Effects 0.000 description 14
- 230000007246 mechanism Effects 0.000 description 14
- 230000008439 repair process Effects 0.000 description 14
- 206010007559 Cardiac failure congestive Diseases 0.000 description 13
- 206010019233 Headaches Diseases 0.000 description 13
- 210000001765 aortic valve Anatomy 0.000 description 13
- 231100000869 headache Toxicity 0.000 description 13
- 210000000513 rotator cuff Anatomy 0.000 description 13
- 238000011221 initial treatment Methods 0.000 description 12
- 230000000875 corresponding effect Effects 0.000 description 11
- 238000012417 linear regression Methods 0.000 description 11
- 230000015654 memory Effects 0.000 description 11
- 238000012986 modification Methods 0.000 description 11
- 230000004048 modification Effects 0.000 description 11
- 230000001960 triggered effect Effects 0.000 description 11
- 238000003491 array Methods 0.000 description 10
- 238000005259 measurement Methods 0.000 description 10
- 206010027599 migraine Diseases 0.000 description 8
- 208000000094 Chronic Pain Diseases 0.000 description 7
- DRHKJLXJIQTDTD-OAHLLOKOSA-N Tamsulosine Chemical compound CCOC1=CC=CC=C1OCCN[C@H](C)CC1=CC=C(OC)C(S(N)(=O)=O)=C1 DRHKJLXJIQTDTD-OAHLLOKOSA-N 0.000 description 7
- 208000027418 Wounds and injury Diseases 0.000 description 7
- 208000029078 coronary artery disease Diseases 0.000 description 7
- 238000002483 medication Methods 0.000 description 7
- 238000000554 physical therapy Methods 0.000 description 7
- 239000003826 tablet Substances 0.000 description 7
- 229960002613 tamsulosin Drugs 0.000 description 7
- 206010006187 Breast cancer Diseases 0.000 description 6
- 208000026310 Breast neoplasm Diseases 0.000 description 6
- 230000009471 action Effects 0.000 description 6
- 206010012601 diabetes mellitus Diseases 0.000 description 6
- 238000013507 mapping Methods 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 238000012552 review Methods 0.000 description 6
- 230000000391 smoking effect Effects 0.000 description 6
- 230000000007 visual effect Effects 0.000 description 6
- SHXWCVYOXRDMCX-UHFFFAOYSA-N 3,4-methylenedioxymethamphetamine Chemical compound CNC(C)CC1=CC=C2OCOC2=C1 SHXWCVYOXRDMCX-UHFFFAOYSA-N 0.000 description 5
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 5
- 208000002177 Cataract Diseases 0.000 description 5
- 241000110847 Kochia Species 0.000 description 5
- 208000001132 Osteoporosis Diseases 0.000 description 5
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 5
- 206010038848 Retinal detachment Diseases 0.000 description 5
- 208000018286 Shoulder injury Diseases 0.000 description 5
- 208000006673 asthma Diseases 0.000 description 5
- 230000036996 cardiovascular health Effects 0.000 description 5
- 238000002405 diagnostic procedure Methods 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 238000012544 monitoring process Methods 0.000 description 5
- 208000031229 Cardiomyopathies Diseases 0.000 description 4
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 4
- 208000024288 Rotator Cuff injury Diseases 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 4
- 238000013132 cardiothoracic surgery Methods 0.000 description 4
- 230000002596 correlated effect Effects 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 4
- 230000004264 retinal detachment Effects 0.000 description 4
- 230000001360 synchronised effect Effects 0.000 description 4
- 206010002383 Angina Pectoris Diseases 0.000 description 3
- 208000008035 Back Pain Diseases 0.000 description 3
- 208000010392 Bone Fractures Diseases 0.000 description 3
- 201000005569 Gout Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 3
- 229930003779 Vitamin B12 Natural products 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 206010003246 arthritis Diseases 0.000 description 3
- 238000003339 best practice Methods 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 230000000747 cardiac effect Effects 0.000 description 3
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 210000002683 foot Anatomy 0.000 description 3
- 238000011540 hip replacement Methods 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000002414 leg Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 201000005202 lung cancer Diseases 0.000 description 3
- 208000020816 lung neoplasm Diseases 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000036651 mood Effects 0.000 description 3
- 230000003863 physical function Effects 0.000 description 3
- 230000035882 stress Effects 0.000 description 3
- 239000011715 vitamin B12 Substances 0.000 description 3
- 235000019163 vitamin B12 Nutrition 0.000 description 3
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 2
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 206010019280 Heart failures Diseases 0.000 description 2
- 206010024453 Ligament sprain Diseases 0.000 description 2
- 206010027727 Mitral valve incompetence Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 201000002064 aortic valve insufficiency Diseases 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 229960004544 cortisone Drugs 0.000 description 2
- 229940127089 cytotoxic agent Drugs 0.000 description 2
- 238000013479 data entry Methods 0.000 description 2
- 238000013500 data storage Methods 0.000 description 2
- 229910003460 diamond Inorganic materials 0.000 description 2
- 239000010432 diamond Substances 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 208000024798 heartburn Diseases 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 208000024765 knee pain Diseases 0.000 description 2
- 238000009533 lab test Methods 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 238000010801 machine learning Methods 0.000 description 2
- 230000004630 mental health Effects 0.000 description 2
- 230000008450 motivation Effects 0.000 description 2
- 230000000399 orthopedic effect Effects 0.000 description 2
- 230000005195 poor health Effects 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002250 progressing effect Effects 0.000 description 2
- 238000011471 prostatectomy Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000002207 retinal effect Effects 0.000 description 2
- 208000037974 severe injury Diseases 0.000 description 2
- 230000009528 severe injury Effects 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- 240000005020 Acaciella glauca Species 0.000 description 1
- 206010002556 Ankylosing Spondylitis Diseases 0.000 description 1
- 208000025674 Anterior Cruciate Ligament injury Diseases 0.000 description 1
- 206010002942 Apathy Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 208000020446 Cardiac disease Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010072063 Exposure to lead Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000011092 Hand injury Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010060820 Joint injury Diseases 0.000 description 1
- 208000016593 Knee injury Diseases 0.000 description 1
- 206010028391 Musculoskeletal Pain Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000031074 Reinjury Diseases 0.000 description 1
- 206010039203 Road traffic accident Diseases 0.000 description 1
- 208000007613 Shoulder Pain Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 230000004931 aggregating effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 206010002906 aortic stenosis Diseases 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 238000010876 biochemical test Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000003114 blood coagulation factor Substances 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 208000003362 bronchogenic carcinoma Diseases 0.000 description 1
- 238000009104 chemotherapy regimen Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 238000009223 counseling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000021045 dietary change Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007159 enucleation Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000008713 feedback mechanism Effects 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 230000003116 impacting effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000010339 medical test Methods 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 239000000820 nonprescription drug Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 235000017924 poor diet Nutrition 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 208000026455 prostate symptom Diseases 0.000 description 1
- 238000001303 quality assessment method Methods 0.000 description 1
- 238000000275 quality assurance Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 235000003499 redwood Nutrition 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 230000005586 smoking cessation Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 210000000623 ulna Anatomy 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 235000003563 vegetarian diet Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q30/00—Commerce
- G06Q30/02—Marketing; Price estimation or determination; Fundraising
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/20—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
Landscapes
- Engineering & Computer Science (AREA)
- Business, Economics & Management (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Business, Economics & Management (AREA)
- Medical Informatics (AREA)
- Strategic Management (AREA)
- Development Economics (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Primary Health Care (AREA)
- Biomedical Technology (AREA)
- Finance (AREA)
- Accounting & Taxation (AREA)
- Entrepreneurship & Innovation (AREA)
- Pathology (AREA)
- Data Mining & Analysis (AREA)
- Game Theory and Decision Science (AREA)
- Databases & Information Systems (AREA)
- Economics (AREA)
- Marketing (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Theoretical Computer Science (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
Une interface affichant une pluralité de scores de bien-être préalablement déterminés pour une pluralité de patients peut être générée et fournie à un dispositif d'affichage. Les patients peuvent chacun être associés à une caractéristique de patient, à un traitement et/ou à un diagnostic. Dans certains cas, les patients peuvent être associés à un fournisseur de traitement particulier ou à un groupe de fournisseurs de traitement, et une pluralité de scores de bien-être préalablement déterminés peut permettre à un fournisseur de traitement de visualiser rapidement (par l'intermédiaire de l'interface) le bien-être actuel des patients confiés à ses soins. Dans d'autres cas, la pluralité de scores de bien-être préalablement déterminés peut être associée à un diagnostic et à un traitement correspondant de sorte que l'interface fournisse les scores de bien-être pour des patients qui ont subi le traitement, et qu'un spectateur puisse observer la manière dont le traitement a un impact sur les scores de bien-être pour les patients.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662376829P | 2016-08-18 | 2016-08-18 | |
| US62/376,829 | 2016-08-18 | ||
| US15/427,962 US11355247B2 (en) | 2016-02-08 | 2017-02-08 | Systems and methods for determining a wellness score, an improvement score, and/or an effectiveness score with regard to a medical condition and/or treatment |
| US15/427,962 | 2017-02-08 | ||
| PCT/US2017/046170 WO2018034913A1 (fr) | 2016-08-18 | 2017-08-09 | Systèmes et procédés pour déterminer et fournir un affichage d'une pluralité de scores de bien-être |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3034235A1 true CA3034235A1 (fr) | 2018-02-22 |
Family
ID=61196952
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3034235A Pending CA3034235A1 (fr) | 2016-08-18 | 2017-08-09 | Systemes et procedes pour determiner et fournir un affichage d'une pluralite de scores de bien-etre |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2017312809A1 (fr) |
| CA (1) | CA3034235A1 (fr) |
| WO (1) | WO2018034913A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11120906B2 (en) * | 2016-10-20 | 2021-09-14 | Play-it Health, Inc. | System for improving patient medical treatment plan compliance |
| CA3094782A1 (fr) * | 2019-09-30 | 2021-03-30 | Mitchell International, Inc. | Estimation automatique de reparation d`un vehicule par apprentissage ensembliste preferentiel de multiples fonctions d`intelligence artificielle |
| US20210225468A1 (en) * | 2020-01-21 | 2021-07-22 | OutcomeMD, Inc. | Systems, devices, and methods for standardizing a format for medical information received from a plurality of sources, associating the standardized medical information with patient accounts stored in a patient account database, and providing access to the patient account database via medical portal interfaces |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008045577A2 (fr) * | 2006-10-13 | 2008-04-17 | Michael Rothman & Associates | Système et procédé pour fournir une notation de santé pour un patient |
| US20150356701A1 (en) * | 2014-06-06 | 2015-12-10 | Play-it Health, Inc. | Monitoring and adapting a patient's medical regimen and facilitating communication with a caregiver |
| US10475540B2 (en) * | 2014-11-03 | 2019-11-12 | Cerner Innovation, Inc. | Impactability scoring |
-
2017
- 2017-08-09 AU AU2017312809A patent/AU2017312809A1/en not_active Abandoned
- 2017-08-09 CA CA3034235A patent/CA3034235A1/fr active Pending
- 2017-08-09 WO PCT/US2017/046170 patent/WO2018034913A1/fr active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2018034913A1 (fr) | 2018-02-22 |
| AU2017312809A1 (en) | 2019-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220384046A1 (en) | Systems and methods for determining and providing a display of a plurality of wellness scores for patients with regard to a medical condition and/or a medical treatment | |
| US20220392644A1 (en) | Systems and methods for determining a wellness score, an improvement score, and/or an effectiveness score with regard to a medical condition and/or medical treatment | |
| US11838365B1 (en) | Patient engagement with clinical trial participants through actionable insights and customized health information | |
| US10311036B1 (en) | Database management for a logical registry | |
| McGwin et al. | Rate of eye injury in the United States | |
| TWI557679B (zh) | 用以產生即時保健警訊的系統與方法 | |
| US20210134444A1 (en) | Correlating Patient Health Characteristics with Relevant Treating Clinicians | |
| EP3504650A1 (fr) | Gestion de parcours de soins | |
| US20080183497A1 (en) | Method and apparatus for internet-based community of health experts | |
| US20190228848A1 (en) | Systems, devices, and methods for generating a medical note interface | |
| US20230035208A1 (en) | Clinical trial/patient follow-up platform | |
| US20210225468A1 (en) | Systems, devices, and methods for standardizing a format for medical information received from a plurality of sources, associating the standardized medical information with patient accounts stored in a patient account database, and providing access to the patient account database via medical portal interfaces | |
| Foraker et al. | EHR-based visualization tool: adoption rates, satisfaction, and patient outcomes | |
| US20110087503A1 (en) | System and method of providing patients incentives for healthy behaviors | |
| Dawn et al. | Patient expectations regarding eye care: focus group results | |
| CA3034235A1 (fr) | Systemes et procedes pour determiner et fournir un affichage d'une pluralite de scores de bien-etre | |
| Rossi et al. | Nursing knowledge captured in electronic health records | |
| US20110087077A1 (en) | System and method of providing patients cost saving incentives for healthy behaviors | |
| US20220270729A1 (en) | Systems, devices, and methods for generating and displaying medical report interfaces and reports for communication to a third party | |
| US20230036984A1 (en) | Systems, devices, and methods for communicating a wellness score and/or an improvement score to an online platform and/or website and for verifying same | |
| Huebinger et al. | Disentangling the Complex Web of Out-of-Hospital Cardiac Arrest Socioeconomic Disparities | |
| RU2750057C1 (ru) | Способ и система оптимизации лечебно-диагностической медицинской помощи | |
| WO2013016143A1 (fr) | Analyse de résultats de thérapie médicale | |
| Jackson et al. | Work time estimates for ophthalmic diagnoses and procedures: Results from the Eye Care Workforce Study | |
| US20210174915A1 (en) | Bi-directional documentation building system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20220809 |
|
| EEER | Examination request |
Effective date: 20220809 |
|
| EEER | Examination request |
Effective date: 20220809 |
|
| EEER | Examination request |
Effective date: 20220809 |